CGTX Annual FCF
-$16.16 M
+$2.54 M+13.57%
31 December 2023
Summary:
As of January 21, 2025, CGTX annual free cash flow is -$16.16 million, with the most recent change of +$2.54 million (+13.57%) on December 31, 2023. During the last 3 years, it has fallen by -$12.72 million (-369.50%). CGTX annual FCF is now -398.61% below its all-time high of -$3.24 million, reached on December 31, 2019.CGTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGTX Quarterly FCF
-$6.85 M
-$851.00 K-14.18%
30 September 2024
Summary:
As of January 21, 2025, CGTX quarterly free cash flow is -$6.85 million, with the most recent change of -$851.00 thousand (-14.18%) on September 30, 2024. Over the past year, it has dropped by -$2.63 million (-62.38%). CGTX quarterly FCF is now -1417.50% below its all-time high of $520.00 thousand, reached on March 31, 2020.CGTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGTX TTM FCF
-$25.58 M
-$2.63 M-11.47%
30 September 2024
Summary:
As of January 21, 2025, CGTX TTM free cash flow is -$25.58 million, with the most recent change of -$2.63 million (-11.47%) on September 30, 2024. Over the past year, it has dropped by -$4.71 million (-22.56%). CGTX TTM FCF is now -5019.42% below its all-time high of $520.00 thousand, reached on March 31, 2020.CGTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CGTX Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +13.6% | -62.4% | -22.6% |
3 y3 years | -369.5% | -62.4% | -22.6% |
5 y5 years | -398.6% | -62.4% | -22.6% |
CGTX Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -341.9% | +13.6% | -6883.2% | +32.8% | -604.5% | at low |
5 y | 5-year | -398.6% | +13.6% | -1417.5% | +32.8% | -5019.4% | at low |
alltime | all time | -398.6% | +13.6% | -1417.5% | +32.8% | -5019.4% | at low |
Cognition Therapeutics Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$6.85 M(+14.2%) | -$25.58 M(+11.5%) |
June 2024 | - | -$6.00 M(-17.2%) | -$22.95 M(+11.1%) |
Mar 2024 | - | -$7.24 M(+32.0%) | -$20.66 M(+27.8%) |
Dec 2023 | -$16.16 M(-13.6%) | -$5.49 M(+30.0%) | -$16.16 M(-22.6%) |
Sept 2023 | - | -$4.22 M(+13.6%) | -$20.87 M(+25.1%) |
June 2023 | - | -$3.71 M(+35.3%) | -$16.68 M(-9.0%) |
Mar 2023 | - | -$2.75 M(-73.1%) | -$18.33 M(-2.0%) |
Dec 2022 | -$18.70 M | -$10.19 M(>+9900.0%) | -$18.70 M(+122.4%) |
Sept 2022 | - | -$27.00 K(-99.5%) | -$8.41 M(-19.4%) |
June 2022 | - | -$5.36 M(+71.7%) | -$10.43 M(+74.4%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$3.12 M(-3191.1%) | -$5.98 M(+64.7%) |
Dec 2021 | -$3.66 M(+6.2%) | $101.00 K(-104.9%) | -$3.63 M(-13.8%) |
Sept 2021 | - | -$2.05 M(+125.3%) | -$4.21 M(+34.9%) |
June 2021 | - | -$910.00 K(+17.9%) | -$3.12 M(-34.0%) |
Mar 2021 | - | -$772.00 K(+60.8%) | -$4.74 M(+37.5%) |
Dec 2020 | -$3.44 M(+6.2%) | -$480.00 K(-50.1%) | -$3.44 M(+16.2%) |
Sept 2020 | - | -$961.00 K(-61.9%) | -$2.96 M(+48.0%) |
June 2020 | - | -$2.52 M(-585.0%) | -$2.00 M(-485.0%) |
Mar 2020 | - | $520.00 K | $520.00 K |
Dec 2019 | -$3.24 M | - | - |
FAQ
- What is Cognition Therapeutics annual free cash flow?
- What is the all time high annual FCF for Cognition Therapeutics?
- What is Cognition Therapeutics annual FCF year-on-year change?
- What is Cognition Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Cognition Therapeutics?
- What is Cognition Therapeutics quarterly FCF year-on-year change?
- What is Cognition Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Cognition Therapeutics?
- What is Cognition Therapeutics TTM FCF year-on-year change?
What is Cognition Therapeutics annual free cash flow?
The current annual FCF of CGTX is -$16.16 M
What is the all time high annual FCF for Cognition Therapeutics?
Cognition Therapeutics all-time high annual free cash flow is -$3.24 M
What is Cognition Therapeutics annual FCF year-on-year change?
Over the past year, CGTX annual free cash flow has changed by +$2.54 M (+13.57%)
What is Cognition Therapeutics quarterly free cash flow?
The current quarterly FCF of CGTX is -$6.85 M
What is the all time high quarterly FCF for Cognition Therapeutics?
Cognition Therapeutics all-time high quarterly free cash flow is $520.00 K
What is Cognition Therapeutics quarterly FCF year-on-year change?
Over the past year, CGTX quarterly free cash flow has changed by -$2.63 M (-62.38%)
What is Cognition Therapeutics TTM free cash flow?
The current TTM FCF of CGTX is -$25.58 M
What is the all time high TTM FCF for Cognition Therapeutics?
Cognition Therapeutics all-time high TTM free cash flow is $520.00 K
What is Cognition Therapeutics TTM FCF year-on-year change?
Over the past year, CGTX TTM free cash flow has changed by -$4.71 M (-22.56%)